ERCC3 and hepatocellular carcinoma: Noticeably, the protein levels of c-Myc and ERCC3 were up-regulated in most of HCC cell lines compared with normal liver cell line LO2 (Fig. 6e), suggesting that inhibiting c-Myc/ERCC3 should be a feasible strategy for the treatment of HCC.